COST INDEX
Tirz yr-one floor $139✓ audSema yr-one floor $119✓ audAbsolute floor · micro $110✓ audFifty 410 prepay ~$133on recHims w/ 12-mo term ~$165on recHenry no-term ~$149on recMochi $79+medon recAltRx promo door ~$89on recRemedy promo door $99→on recShedRx entry ~$199on recZepbound vial $349shelfWegovy self-pay $499shelf
VSCompareGLP1ProvidersYEAR-ONE MATH · LIVE-CHECKOUT AUDITSFind my program →

Quick answer · /answers/ cluster · Pricing architecture

What is Flat Forever pricing?

THE SHORT ANSWER

Flat Forever is NexLife’s written dose-proof policy: your monthly price never changes when your dose does. Start at 2.5 mg tirzepatide and titrate to 15 mg — still $139 on the twelve-month plan; climb semaglutide’s near-tenfold ladder — still $119. Against dose-scaled programs (where standard titration triggers built-in price increases toward $199–$299 tiers), the clause is worth roughly $1,000 in year one and compounds every maintenance year after. Its second effect is subtler: removing money from the dosing conversation, so neither patient nor prescriber has a financial reason to under-treat.

The clause was verified in our 2026-08-14 audit — written policy, not marketing copy — and it’s the reason the ten-second provider sort (“if my dose doubles, what happens to my bill?”) opens every money page here: the flat-rate file, the maintenance file, the higher-dose file. Field-wide contrast with dates: the cost index.

SECOND VISIT?

Stop re-reading tabs — answer three questions and the field sorts itself. No email, no account.

Sort the field for me →